Landing Point Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Hold
628
0.26% 50
2026
Q1
$577K Sell
628
-17
-3% -$17.2K 0.28% 44
2025
Q4
$694K Hold
645
0.35% 37
2025
Q3
$492K Buy
645
+206
+47% +$153K 0.26% 49
2025
Q2
$342K Buy
439
+5
+1% +$3.88K 0.22% 50
2025
Q1
$358K Sell
434
-32
-7% -$26.6K 0.27% 45
2024
Q4
$407K Buy
+466
New +$386K 0.31% 38

Other funds holding LLY

Landing Point Financial Group's LLY Position: Q2 2026 in Review

Landing Point Financial Group held its Eli Lilly (LLY) position steady in Q2 2026 at 628 shares worth $753K. The position accounts for 0.26% of the portfolio, ranked #50.

Landing Point Financial Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Landing Point Financial Group held 628 shares of Eli Lilly worth $753K as of Q2 2026.
  • Landing Point Financial Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.26% of Landing Point Financial Group's portfolio in Q2 2026, its #50 holding.
  • Landing Point Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Landing Point Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.